AAAAAA
Results:
1-14
|
Results: 14
Authors:
Sweeney, CJ
Grafe, A
Shyn, TW
Citation: Cj. Sweeney et al., Measurement of absolute differential cross sections for the excitation of atomic hydrogen to its n=3 and 4 levels by electron impact - art. no. 032704, PHYS REV A, 6403(3), 2001, pp. 2704
Authors:
Grafe, A
Sweeney, CJ
Shyn, TW
Citation: A. Grafe et al., Measurement of absolute differential cross sections for the excitation of atomic hydrogen to its n=2 level by electron impact - art. no. 052715, PHYS REV A, 6305(5), 2001, pp. 2715
Authors:
Miller, KD
Sweeney, CJ
Sledge, GW
Citation: Kd. Miller et al., Redefining the target: Chemotherapeutics as antiangiogenics, J CL ONCOL, 19(4), 2001, pp. 1195-1206
Authors:
Yip-Schneider, MT
Sweeney, CJ
Jung, SH
Crowell, PL
Marshall, MS
Citation: Mt. Yip-schneider et al., Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells, J PHARM EXP, 298(3), 2001, pp. 976-985
Authors:
Sweeney, CJ
Gilden, DH
Citation: Cj. Sweeney et Dh. Gilden, Ramsay Hunt syndrome, J NE NE PSY, 71(2), 2001, pp. 149-154
Authors:
Sweeney, CJ
Miller, KD
Sissons, SE
Nozaki, S
Heilman, DK
Shen, JZ
Sledge, GW
Citation: Cj. Sweeney et al., The antiangiogenic property of docetaxel is synergistic with a recombinanthumanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors, CANCER RES, 61(8), 2001, pp. 3369-3372
Authors:
Sweeney, CJ
Zhu, JM
Sandler, AB
Schiller, J
Belani, CP
Langer, C
Krook, J
Harrington, D
Johnson, DH
Citation: Cj. Sweeney et al., Outcome of patients with a performance status of 2 in Eastern cooperative oncology group study E1594 - A phase III trial in patients with metastatic nonsmall cell lung carcinoma, CANCER, 92(10), 2001, pp. 2639-2647
Authors:
Shyn, TW
Sweeney, CJ
Citation: Tw. Shyn et Cj. Sweeney, Measurement of absolute differential excitation cross sections of molecular oxygen by electron impact: Decomposition of the Herzberg pseudocontinuum - art. no. 022711, PHYS REV A, 6202(2), 2000, pp. 2711
Authors:
Sweeney, CJ
Hermans, BP
Heilman, DK
Foster, RS
Donohue, JP
Einhorn, LH
Citation: Cj. Sweeney et al., Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma-predominant testis cancer, J CL ONCOL, 18(2), 2000, pp. 358-362
Authors:
Sweeney, CJ
Sandler, AB
Citation: Cj. Sweeney et Ab. Sandler, Chemotherapy in non-small cell lung cancer, INV NEW DR, 18(2), 2000, pp. 157-186
Authors:
Yip-Schneider, MT
Barnard, DS
Billings, SD
Cheng, L
Heilman, DK
Lin, A
Marshall, SJ
Crowell, PL
Marshall, MS
Sweeney, CJ
Citation: Mt. Yip-schneider et al., Cyclooxygenase-2 expression in human pancreatic adenocarcinomas, CARCINOGENE, 21(2), 2000, pp. 139-146
Authors:
Hermans, BP
Sweeney, CJ
Foster, RS
Einhorn, LE
Donohue, JP
Citation: Bp. Hermans et al., Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection, J UROL, 163(6), 2000, pp. 1721-1724
Authors:
Yip-Schneider, MT
Lin, A
Barnard, D
Sweeney, CJ
Marshall, MS
Citation: Mt. Yip-schneider et al., Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression, INT J ONCOL, 15(2), 1999, pp. 271-279
Authors:
Sweeney, CJ
Williams, SD
Finch, DE
Bihrle, R
Foster, RS
Collins, M
Fox, S
Roth, BJ
Citation: Cj. Sweeney et al., A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium, CANCER, 86(3), 1999, pp. 514-518
Risultati:
1-14
|